companydata.dkcompanydata.dk

REPOCEUTICALS A/S: Financial statements 2024

CVR: 36494433

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

REPOCEUTICALS A/S (CVR 36494433) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK -6,274,548 compared with DKK -5,199,745 the year before. Equity in the 2024 report amounted to DKK 4,791,848. The solvency ratio was 39.7%.

Revenue
DKK 0
Profit/Loss
DKK -6,274,548
Equity
DKK 4,791,848
Total Assets
DKK 12,055,798

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202400-6.3M4.8M-
202300-5.2M2.8M-
202200-3.8M8.3M-
202100-4.4M12M-
202000-859K5.2M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

REPOCEUTICALS A/S: The 2023 annual report is outJun 20, 2024

REPOCEUTICALS A/S has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -5,199,745.

Troels Peter Troelsen joins the board of REPOCEUTICALS A/SJun 13, 2024

As of June 13, 2024, Troels Peter Troelsen has joined the board of directors of REPOCEUTICALS A/S.

Sigbjørn Georg Nielsen Kjærgård joins the board of REPOCEUTICALS A/SJun 13, 2024

As of June 13, 2024, Sigbjørn Georg Nielsen Kjærgård has joined the board of directors of REPOCEUTICALS A/S.

Troels Peter Troelsen leaves the board of REPOCEUTICALS A/SJun 12, 2024

As of June 12, 2024, Troels Peter Troelsen has left the board of directors of REPOCEUTICALS A/S.

Sigbjørn Georg Nielsen Kjærgård leaves the board of REPOCEUTICALS A/SJun 12, 2024

As of June 12, 2024, Sigbjørn Georg Nielsen Kjærgård has left the board of directors of REPOCEUTICALS A/S.

About REPOCEUTICALS A/S

REPOCEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPOCEUTICALS ApS. The management consists of Torsten Bjørn. The board consists of Henrik Bulskov (chair), Charlotte Pahl and Christian Vinding Thomsen. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and DMZ HOLDING ApS. The company has 2 employees (2026). In 2025, the company reported revenue of DKK 88,000,000 and a net result of DKK -6,228,938,000 compared with DKK -6,274,548 the year before. Equity in the 2025 report amounted to DKK 6,245,088,000.

Source: annual report 2025, Danish Business Authority